BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

936 related articles for article (PubMed ID: 29175753)

  • 1. Chicoric acid prevents PDGF-BB-induced VSMC dedifferentiation, proliferation and migration by suppressing ROS/NFκB/mTOR/P70S6K signaling cascade.
    Lu QB; Wan MY; Wang PY; Zhang CX; Xu DY; Liao X; Sun HJ
    Redox Biol; 2018 Apr; 14():656-668. PubMed ID: 29175753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zedoarondiol Inhibits Platelet-Derived Growth Factor-Induced Vascular Smooth Muscle Cells Proliferation via Regulating AMP-Activated Protein Kinase Signaling Pathway.
    Mao H; Tao T; Song D; Liu M; Wang X; Liu X; Shi D
    Cell Physiol Biochem; 2016; 40(6):1506-1520. PubMed ID: 27997894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of autophagy by controlling Erk1/2 and mTOR for platelet-derived growth factor-BB-mediated vascular smooth muscle cell phenotype shift.
    Han JH; Park HS; Lee DH; Jo JH; Heo KS; Myung CS
    Life Sci; 2021 Feb; 267():118978. PubMed ID: 33412209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of AMPK by Telmisartan Decreases Basal and PDGF-stimulated VSMC Proliferation via Inhibiting the mTOR/p70S6K Signaling Axis.
    Hwang YJ; Park JH; Cho DH
    J Korean Med Sci; 2020 Sep; 35(35):e289. PubMed ID: 32893519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of p90RSK Ameliorates PDGF-BB-Mediated Phenotypic Change of Vascular Smooth Muscle Cell and Subsequent Hyperplasia of Neointima.
    Hwang AR; Lee HJ; Kim S; Park SH; Woo CH
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulforaphane inhibits platelet-derived growth factor-induced vascular smooth muscle cell proliferation by targeting mTOR/p70S6kinase signaling independent of Nrf2 activation.
    Shawky NM; Segar L
    Pharmacol Res; 2017 May; 119():251-264. PubMed ID: 28212891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apamin inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration through suppressions of activated Akt and Erk signaling pathway.
    Kim JY; Kim KH; Lee WR; An HJ; Lee SJ; Han SM; Lee KG; Park YY; Kim KS; Lee YS; Park KK
    Vascul Pharmacol; 2015 Jul; 70():8-14. PubMed ID: 25737404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salusin-β Promotes Vascular Smooth Muscle Cell Migration and Intimal Hyperplasia After Vascular Injury via ROS/NFκB/MMP-9 Pathway.
    Sun HJ; Zhao MX; Ren XS; Liu TY; Chen Q; Li YH; Kang YM; Wang JJ; Zhu GQ
    Antioxid Redox Signal; 2016 Jun; 24(18):1045-57. PubMed ID: 26952533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiproliferative activity of NQ304, a synthetic 1,4-naphthoquinone, is mediated via the suppressions of the PI3K/Akt and ERK1/2 signaling pathways in PDGF-BB-stimulated vascular smooth muscle cells.
    Kim TJ; Yun YP
    Vascul Pharmacol; 2007 Jan; 46(1):43-51. PubMed ID: 16875883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble epoxide hydrolase is involved in the development of atherosclerosis and arterial neointima formation by regulating smooth muscle cell migration.
    Wang Q; Huo L; He J; Ding W; Su H; Tian D; Welch C; Hammock BD; Ai D; Zhu Y
    Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1894-903. PubMed ID: 26453326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apatinib attenuates phenotypic switching of arterial smooth muscle cells in vascular remodelling by targeting the PDGF Receptor-β.
    Shao W; Li X; Peng J; Fan S; Liang M; Huang K
    J Cell Mol Med; 2020 Sep; 24(17):10128-10139. PubMed ID: 32697395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3,3'Diindolylmethane suppresses vascular smooth muscle cell phenotypic modulation and inhibits neointima formation after carotid injury.
    Guan H; Zhu L; Fu M; Yang D; Tian S; Guo Y; Cui C; Wang L; Jiang H
    PLoS One; 2012; 7(4):e34957. PubMed ID: 22506059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin calcium inhibits phenotypic modulation of PDGF-BB-induced VSMCs via down-regulation the Akt signaling pathway.
    Chen S; Liu B; Kong D; Li S; Li C; Wang H; Sun Y
    PLoS One; 2015; 10(4):e0122577. PubMed ID: 25874930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermedin reduces neointima formation by regulating vascular smooth muscle cell phenotype via cAMP/PKA pathway.
    Zhu Q; Ni XQ; Lu WW; Zhang JS; Ren JL; Wu D; Chen Y; Zhang LS; Yu YR; Tang CS; Qi YF
    Atherosclerosis; 2017 Nov; 266():212-222. PubMed ID: 29053988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrogen-rich saline prevents neointima formation after carotid balloon injury by suppressing ROS and the TNF-α/NF-κB pathway.
    Qin ZX; Yu P; Qian DH; Song MB; Tan H; Yu Y; Li W; Wang H; Liu J; Wang Q; Sun XJ; Jiang H; Zhu JK; Lu W; Huang L
    Atherosclerosis; 2012 Feb; 220(2):343-50. PubMed ID: 22153150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic treatment with PDGF-BB and endothelin-1 synergistically induces vascular hyperplasia and loss of contractility in organ-cultured rat tail artery.
    Kida T; Chuma H; Murata T; Yamawaki H; Matsumoto S; Hori M; Ozaki H
    Atherosclerosis; 2011 Feb; 214(2):288-94. PubMed ID: 21129745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid inhibits dedifferentiation of PDGF-BB-induced vascular smooth muscle cells by suppressing mTOR/P70S6K signaling.
    Pan S; Lin H; Luo H; Gao F; Meng L; Zhou C; Jiang C; Guo Y; Ji Z; Chi J; Guo H
    Am J Transl Res; 2017; 9(3):1307-1316. PubMed ID: 28386356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursodeoxycholic acid inhibits intimal hyperplasia, vascular smooth muscle cell excessive proliferation, migration via blocking miR-21/PTEN/AKT/mTOR signaling pathway.
    Huang R; Huang Y; Zeng G; Li M; Jin Y
    Cell Cycle; 2020 Apr; 19(8):918-932. PubMed ID: 32202193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carvacrol inhibits atherosclerotic neointima formation by downregulating reactive oxygen species production in vascular smooth muscle cells.
    Lee KP; Sudjarwo GW; Jung SH; Lee D; Lee DY; Lee GB; Baek S; Kim DY; Lee HM; Kim B; Kwon SC; Won KJ
    Atherosclerosis; 2015 Jun; 240(2):367-73. PubMed ID: 25875388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RhoGDI3 at the trans-Golgi network participates in NLRP3 inflammasome activation, VSMC phenotypic modulation, and neointima formation.
    Sun J; Zhu Q; Yu X; Liang X; Guan H; Zhao H; Yao W
    Atherosclerosis; 2023 Dec; 387():117391. PubMed ID: 38029612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.